Cooper Companies ( COO) pushed the Health Services industry lower today making it today's featured Health Services loser. The industry as a whole closed the day up 1.3%. By the end of trading, Cooper Companies fell $1.24 (-1.6%) to $78.82 on heavy volume. Throughout the day, 2.4 million shares of Cooper Companies exchanged hands as compared to its average daily volume of 458,200 shares. The stock ranged in price between $75.41-$79.33 after having opened the day at $75.67 as compared to the previous trading day's close of $80.06. Other company's within the Health Services industry that declined today were: ImmunoCellular Therapeutics ( IMUC), down 11.9%, Urologix ( ULGX), down 11.7%, Strategic Diagnostics ( SDIX), down 7.2%, and Oculus Innovative ( OCLS), down 6.8%. The Cooper Companies, Inc. engages in the provision of medical devices for healthcare professionals worldwide. Cooper Companies has a market cap of $3.89 billion and is part of the health care sector. The company has a P/E ratio of 21, below the average health services industry P/E ratio of 21.6 and above the S&P 500 P/E ratio of 17.7. Shares are up 15.2% year to date as of the close of trading on Thursday. Currently there are five analysts that rate Cooper Companies a buy, no analysts rate it a sell, and three rate it a hold. TheStreet Ratings rates Cooper Companies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow.